Selected research
Market Outlook & Growth Opportunities
Global Gene Expression Screening Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Gene Expression Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Gene Expression Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Gene Expression Screening Service market include EKF Diagnostics, Perkin Elmer, IntegraGen, Quest Diagnostics, Abbott Laboratories, Roche Diagnostics, Biocartis, Elitech Group and Interpace Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Gene Expression Screening Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Expression Screening Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Expression Screening Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Expression Screening Service market.
Gene Expression Screening Service Segment by Company
EKF Diagnostics
Perkin Elmer
IntegraGen
Quest Diagnostics
Abbott Laboratories
Roche Diagnostics
Biocartis
Elitech Group
Interpace Diagnostics
Qiagen
AutoGenomics
Bio-Rad Laboratories
Cepheid
Gene Expression Screening Service Segment by Type
High-Throughput Screening
Low-Throughput Screening
Gene Expression Screening Service Segment by Application
Pharmaceutical Industry
Agricultural Industry
Environmental Science
Others
Gene Expression Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Gene Expression Screening Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Expression Screening Service key companies, revenue, market share, and recent developments.
3. To split the Gene Expression Screening Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Expression Screening Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Expression Screening Service significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Expression Screening Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Expression Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Expression Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Expression Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Expression Screening Service industry.
Chapter 3: Detailed analysis of Gene Expression Screening Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Expression Screening Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Expression Screening Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Gene Expression Screening Service Industry Trends
Table 2. Gene Expression Screening Service Industry Drivers
Table 3. Gene Expression Screening Service Industry Opportunities and Challenges
Table 4. Gene Expression Screening Service Industry Restraints
Table 5. Global Gene Expression Screening Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Gene Expression Screening Service Revenue Share by Company (2021-2026)
Table 7. Global Gene Expression Screening Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Gene Expression Screening Service Key Company Manufacturing Base & Headquarters
Table 9. Global Gene Expression Screening Service Company, Product Type & Application
Table 10. Global Gene Expression Screening Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Gene Expression Screening Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of High-Throughput Screening
Table 15. Significant Companies of Low-Throughput Screening
Table 16. Global Gene Expression Screening Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Gene Expression Screening Service Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Gene Expression Screening Service Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Gene Expression Screening Service Sales Value Share by Type (2021-2026)
Table 20. Global Gene Expression Screening Service Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Pharmaceutical Industry
Table 22. Significant Companies of Agricultural Industry
Table 23. Significant Companies of Environmental Science
Table 24. Significant Companies of Others
Table 25. Global Gene Expression Screening Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Gene Expression Screening Service Sales Value by Application (2021-2026) & (US$ Million)
Table 27. Global Gene Expression Screening Service Sales Value by Application (2027-2032) & (US$ Million)
Table 28. Global Gene Expression Screening Service Sales Value Share by Application (2021-2026)
Table 29. Global Gene Expression Screening Service Sales Value Share by Application (2027-2032)
Table 30. Global Gene Expression Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Gene Expression Screening Service Sales Value by Region (2021-2026) & (US$ Million)
Table 32. Global Gene Expression Screening Service Sales Value Share by Region (2021-2026)
Table 33. Global Gene Expression Screening Service Sales Value by Region (2027-2032) & (US$ Million)
Table 34. Global Gene Expression Screening Service Sales Value Share by Region (2027-2032)
Table 35. Global Gene Expression Screening Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Gene Expression Screening Service Sales Value by Country (2021-2026) & (US$ Million)
Table 37. Global Gene Expression Screening Service Sales Value Market Share by Country (2021-2026)
Table 38. Global Gene Expression Screening Service Sales Value by Country (2027-2032) & (US$ Million)
Table 39. Global Gene Expression Screening Service Sales Value Market Share by Country (2027-2032)
Table 40. EKF Diagnostics Company Information
Table 41. EKF Diagnostics Business Overview
Table 42. EKF Diagnostics Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 43. EKF Diagnostics Gene Expression Screening Service Product Portfolio
Table 44. EKF Diagnostics Recent Development
Table 45. Perkin Elmer Company Information
Table 46. Perkin Elmer Business Overview
Table 47. Perkin Elmer Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. Perkin Elmer Gene Expression Screening Service Product Portfolio
Table 49. Perkin Elmer Recent Development
Table 50. IntegraGen Company Information
Table 51. IntegraGen Business Overview
Table 52. IntegraGen Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. IntegraGen Gene Expression Screening Service Product Portfolio
Table 54. IntegraGen Recent Development
Table 55. Quest Diagnostics Company Information
Table 56. Quest Diagnostics Business Overview
Table 57. Quest Diagnostics Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. Quest Diagnostics Gene Expression Screening Service Product Portfolio
Table 59. Quest Diagnostics Recent Development
Table 60. Abbott Laboratories Company Information
Table 61. Abbott Laboratories Business Overview
Table 62. Abbott Laboratories Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Abbott Laboratories Gene Expression Screening Service Product Portfolio
Table 64. Abbott Laboratories Recent Development
Table 65. Roche Diagnostics Company Information
Table 66. Roche Diagnostics Business Overview
Table 67. Roche Diagnostics Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Roche Diagnostics Gene Expression Screening Service Product Portfolio
Table 69. Roche Diagnostics Recent Development
Table 70. Biocartis Company Information
Table 71. Biocartis Business Overview
Table 72. Biocartis Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Biocartis Gene Expression Screening Service Product Portfolio
Table 74. Biocartis Recent Development
Table 75. Elitech Group Company Information
Table 76. Elitech Group Business Overview
Table 77. Elitech Group Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Elitech Group Gene Expression Screening Service Product Portfolio
Table 79. Elitech Group Recent Development
Table 80. Interpace Diagnostics Company Information
Table 81. Interpace Diagnostics Business Overview
Table 82. Interpace Diagnostics Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Interpace Diagnostics Gene Expression Screening Service Product Portfolio
Table 84. Interpace Diagnostics Recent Development
Table 85. Qiagen Company Information
Table 86. Qiagen Business Overview
Table 87. Qiagen Gene Expression Screening Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Qiagen Gene Expression Screening Service Product Portfolio
Table 89. Qiagen Recent Development
Table 90. AutoGenomics Company Information
Table 91. AutoGenomics Business Overview
Table 92. AutoGenomics Gene Expression Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 93. AutoGenomics Gene Expression Screening Service Product Portfolio
Table 94. AutoGenomics Recent Development
Table 95. Bio-Rad Laboratories Company Information
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Gene Expression Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 98. Bio-Rad Laboratories Gene Expression Screening Service Product Portfolio
Table 99. Bio-Rad Laboratories Recent Development
Table 100. Cepheid Company Information
Table 101. Cepheid Business Overview
Table 102. Cepheid Gene Expression Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 103. Cepheid Gene Expression Screening Service Product Portfolio
Table 104. Cepheid Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Authors List of This Report
Table 107. Secondary Sources
Table 108. Primary Sources
List of Figures
Figure 1. Gene Expression Screening Service Product Image
Figure 2. Global Gene Expression Screening Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Gene Expression Screening Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Gene Expression Screening Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. High-Throughput Screening Image
Figure 8. Low-Throughput Screening Image
Figure 9. Global Gene Expression Screening Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Gene Expression Screening Service Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Gene Expression Screening Service Sales Value Share by Type (2021-2032)
Figure 12. Pharmaceutical Industry Image
Figure 13. Agricultural Industry Image
Figure 14. Environmental Science Image
Figure 15. Others Image
Figure 16. Global Gene Expression Screening Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Gene Expression Screening Service Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Gene Expression Screening Service Sales Value Share by Application (2021-2032)
Figure 19. Global Gene Expression Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 20. Global Gene Expression Screening Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 21. North America Gene Expression Screening Service Sales Value (2021-2032) & (US$ Million)
Figure 22. North America Gene Expression Screening Service Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Europe Gene Expression Screening Service Sales Value (2021-2032) & (US$ Million)
Figure 24. Europe Gene Expression Screening Service Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Asia-Pacific Gene Expression Screening Service Sales Value (2021-2032) & (US$ Million)
Figure 26. Asia-Pacific Gene Expression Screening Service Sales Value Share by Country (%), 2025 VS 2032
Figure 27. South America Gene Expression Screening Service Sales Value (2021-2032) & (US$ Million)
Figure 28. South America Gene Expression Screening Service Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Middle East & Africa Gene Expression Screening Service Sales Value (2021-2032) & (US$ Million)
Figure 30. Middle East & Africa Gene Expression Screening Service Sales Value Share by Country (%), 2025 VS 2032
Figure 31. USA Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 32. USA Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 33. USA Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 34. Canada Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. Canada Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. Canada Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Mexico Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Mexico Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Mexico Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Germany Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Germany Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Germany Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. France Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. France Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. France Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. U.K. Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. U.K. Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. U.K. Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Italy Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Italy Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Italy Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Spain Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Spain Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Spain Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Russia Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Russia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Russia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Netherlands Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Netherlands Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Netherlands Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Nordic Countries Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. China Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. China Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. China Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Japan Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Japan Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Japan Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. South Korea Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. South Korea Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. South Korea Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. India Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. India Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. India Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Australia Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Australia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Australia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Southeast Asia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Brazil Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Brazil Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Brazil Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Argentina Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Argentina Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Argentina Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Chile Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Chile Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Chile Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Colombia Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Colombia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Colombia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Peru Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Peru Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Peru Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Saudi Arabia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Israel Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Israel Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Israel Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. UAE Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. UAE Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. UAE Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Turkey Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Turkey Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Turkey Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Iran Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Iran Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Iran Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Egypt Gene Expression Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Egypt Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Egypt Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Years Considered
Figure 116. Research Process
Figure 117. Key Executives Interviewed
Scope & coverage.
Types
- High-Throughput Screening
- Low-Throughput Screening
Applications
- Pharmaceutical Industry
- Agricultural Industry
- Environmental Science
- Others
Companies covered
- EKF Diagnostics
- Perkin Elmer
- IntegraGen
- Quest Diagnostics
- Abbott Laboratories
- Roche Diagnostics
- Biocartis
- Elitech Group
- Interpace Diagnostics
- Qiagen
- AutoGenomics
- Bio-Rad Laboratories
- Cepheid
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gene Expression Screening Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gene Expression Screening Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gene Expression Screening Service Market Dynamics
- 2.1 Gene Expression Screening Service Industry Trends
- 2.2 Gene Expression Screening Service Industry Drivers
- 2.3 Gene Expression Screening Service Industry Opportunities and Challenges
- 2.4 Gene Expression Screening Service Industry Restraints
3 Gene Expression Screening Service Market by Company
- 3.1 Global Gene Expression Screening Service Company Revenue Ranking in 2025
- 3.2 Global Gene Expression Screening Service Revenue by Company (2021-2026)
- 3.3 Global Gene Expression Screening Service Company Ranking (2024-2026)
- 3.4 Global Gene Expression Screening Service Company Manufacturing Base and Headquarters
- 3.5 Global Gene Expression Screening Service Company Product Type and Application
- 3.6 Global Gene Expression Screening Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Gene Expression Screening Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Gene Expression Screening Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Gene Expression Screening Service Market by Type
- 4.1 Gene Expression Screening Service Type Introduction
- 4.1.1 High-Throughput Screening
- 4.1.2 Low-Throughput Screening
- 4.2 Global Gene Expression Screening Service Sales Value by Type
- 4.2.1 Global Gene Expression Screening Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gene Expression Screening Service Sales Value by Type (2021-2032)
- 4.2.3 Global Gene Expression Screening Service Sales Value Share by Type (2021-2032)
5 Gene Expression Screening Service Market by Application
- 5.1 Gene Expression Screening Service Application Introduction
- 5.1.1 Pharmaceutical Industry
- 5.1.2 Agricultural Industry
- 5.1.3 Environmental Science
- 5.1.4 Others
- 5.2 Global Gene Expression Screening Service Sales Value by Application
- 5.2.1 Global Gene Expression Screening Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gene Expression Screening Service Sales Value by Application (2021-2032)
- 5.2.3 Global Gene Expression Screening Service Sales Value Share by Application (2021-2032)
6 Gene Expression Screening Service Regional Value Analysis
- 6.1 Global Gene Expression Screening Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gene Expression Screening Service Sales Value by Region (2021-2032)
- 6.2.1 Global Gene Expression Screening Service Sales Value by Region: 2021-2026
- 6.2.2 Global Gene Expression Screening Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gene Expression Screening Service Sales Value (2021-2032)
- 6.3.2 North America Gene Expression Screening Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Gene Expression Screening Service Sales Value (2021-2032)
- 6.4.2 Europe Gene Expression Screening Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Gene Expression Screening Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Gene Expression Screening Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Gene Expression Screening Service Sales Value (2021-2032)
- 6.6.2 South America Gene Expression Screening Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Gene Expression Screening Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Gene Expression Screening Service Sales Value Share by Country, 2025 VS 2032
7 Gene Expression Screening Service Country-level Value Analysis
- 7.1 Global Gene Expression Screening Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Gene Expression Screening Service Sales Value by Country (2021-2032)
- 7.2.1 Global Gene Expression Screening Service Sales Value by Country (2021-2026)
- 7.2.2 Global Gene Expression Screening Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Gene Expression Screening Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Gene Expression Screening Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Gene Expression Screening Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 EKF Diagnostics
- 8.1.1 EKF Diagnostics Company Information
- 8.1.2 EKF Diagnostics Business Overview
- 8.1.3 EKF Diagnostics Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.1.4 EKF Diagnostics Gene Expression Screening Service Product Portfolio
- 8.1.5 EKF Diagnostics Recent Developments
- 8.2 Perkin Elmer
- 8.2.1 Perkin Elmer Company Information
- 8.2.2 Perkin Elmer Business Overview
- 8.2.3 Perkin Elmer Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Perkin Elmer Gene Expression Screening Service Product Portfolio
- 8.2.5 Perkin Elmer Recent Developments
- 8.3 IntegraGen
- 8.3.1 IntegraGen Company Information
- 8.3.2 IntegraGen Business Overview
- 8.3.3 IntegraGen Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.3.4 IntegraGen Gene Expression Screening Service Product Portfolio
- 8.3.5 IntegraGen Recent Developments
- 8.4 Quest Diagnostics
- 8.4.1 Quest Diagnostics Company Information
- 8.4.2 Quest Diagnostics Business Overview
- 8.4.3 Quest Diagnostics Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Quest Diagnostics Gene Expression Screening Service Product Portfolio
- 8.4.5 Quest Diagnostics Recent Developments
- 8.5 Abbott Laboratories
- 8.5.1 Abbott Laboratories Company Information
- 8.5.2 Abbott Laboratories Business Overview
- 8.5.3 Abbott Laboratories Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Abbott Laboratories Gene Expression Screening Service Product Portfolio
- 8.5.5 Abbott Laboratories Recent Developments
- 8.6 Roche Diagnostics
- 8.6.1 Roche Diagnostics Company Information
- 8.6.2 Roche Diagnostics Business Overview
- 8.6.3 Roche Diagnostics Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Roche Diagnostics Gene Expression Screening Service Product Portfolio
- 8.6.5 Roche Diagnostics Recent Developments
- 8.7 Biocartis
- 8.7.1 Biocartis Company Information
- 8.7.2 Biocartis Business Overview
- 8.7.3 Biocartis Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Biocartis Gene Expression Screening Service Product Portfolio
- 8.7.5 Biocartis Recent Developments
- 8.8 Elitech Group
- 8.8.1 Elitech Group Company Information
- 8.8.2 Elitech Group Business Overview
- 8.8.3 Elitech Group Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Elitech Group Gene Expression Screening Service Product Portfolio
- 8.8.5 Elitech Group Recent Developments
- 8.9 Interpace Diagnostics
- 8.9.1 Interpace Diagnostics Company Information
- 8.9.2 Interpace Diagnostics Business Overview
- 8.9.3 Interpace Diagnostics Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Interpace Diagnostics Gene Expression Screening Service Product Portfolio
- 8.9.5 Interpace Diagnostics Recent Developments
- 8.10 Qiagen
- 8.10.1 Qiagen Company Information
- 8.10.2 Qiagen Business Overview
- 8.10.3 Qiagen Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Qiagen Gene Expression Screening Service Product Portfolio
- 8.10.5 Qiagen Recent Developments
- 8.11 AutoGenomics
- 8.11.1 AutoGenomics Company Information
- 8.11.2 AutoGenomics Business Overview
- 8.11.3 AutoGenomics Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.11.4 AutoGenomics Gene Expression Screening Service Product Portfolio
- 8.11.5 AutoGenomics Recent Developments
- 8.12 Bio-Rad Laboratories
- 8.12.1 Bio-Rad Laboratories Company Information
- 8.12.2 Bio-Rad Laboratories Business Overview
- 8.12.3 Bio-Rad Laboratories Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Bio-Rad Laboratories Gene Expression Screening Service Product Portfolio
- 8.12.5 Bio-Rad Laboratories Recent Developments
- 8.13 Cepheid
- 8.13.1 Cepheid Company Information
- 8.13.2 Cepheid Business Overview
- 8.13.3 Cepheid Gene Expression Screening Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Cepheid Gene Expression Screening Service Product Portfolio
- 8.13.5 Cepheid Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst